4//SEC Filing
Lager Joanne Jenkins 4
Accession 0001209191-22-018669
CIK 0001808865other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 8:01 PM ET
Size
11.1 KB
Accession
0001209191-22-018669
Insider Transaction Report
Form 4
Lager Joanne Jenkins
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2022-03-11$4.30/sh+3,500$15,050→ 3,500 total - Sale
Common Stock
2022-03-11$36.01/sh−3,500$126,035→ 0 total - Award
Stock Option (Right to Buy)
2022-03-11+85,000→ 85,000 totalExercise: $36.21Exp: 2032-03-11→ Common Stock (85,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2022-03-11−3,500→ 178,938 totalExercise: $4.30Exp: 2025-06-11→ Common Stock (3,500 underlying)
Footnotes (2)
- [F1]This stock option shall vest over 4 years, with 25% vesting on March 11, 2023 and thereafter in equal monthly installments over the next 36 months, subject to the Reporting Person's continued service to the Issuer.
- [F2]One-fourth of the shares subject to the stock option vested on April 1, 2020. Thereafter, 1/48 of the shares subject to the stock option vest on a monthly basis, subject to the reporting person's continuous service relationship with the Issuer through each applicable vesting date
Documents
Issuer
iTeos Therapeutics, Inc.
CIK 0001808865
Entity typeother
Related Parties
1- filerCIK 0001816215
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 8:01 PM ET
- Size
- 11.1 KB